Diagnosis of Alzheimer’s Disease Utilizing Amyloid and Tau as Fluid Biomarkers

Experimental and Molecular Medicine - United States
doi 10.1038/s12276-019-0250-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cerebrospinal Fluid Tau and Phosphotau as Biomarkers in Alzheimer's Disease Diagnosis

Basic and Clinical Neuroscience
Molecular NeuroscienceNeurologyCellular
2019English

Tau Imaging in Alzheimer’s Disease Diagnosis and Clinical Trials

Neurotherapeutics
NeurologyPharmacology
2016English

Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2011English

Microbiosensor for Alzheimer’s Disease Diagnostics: Detection of Amyloid Beta Biomarkers

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2012English

Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders
PsychiatryGerontologyGeriatricsMental HealthCognitive Neuroscience
2008English

Longitudinal Assessment of Tau and Amyloid Beta in Cerebrospinal Fluid of Parkinson Disease

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2013English

GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease

Neuron
Neuroscience
2013English

Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis

Frontiers in Neurology
Neurology
2017English

Biomarkers of Alzheimer’s Disease

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy